Castleark Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,120
| Closed | -$4.71M | – | 310 |
|
|
2025
Q1 | $4.71M | Buy |
+26,120
| New | +$4.71M | 0.16% | 129 |
|
|
2024
Q4 | – | Sell |
-27,290
| Closed | -$4.97M | – | 308 |
|
|
2024
Q3 | $4.97M | Sell |
27,290
-990
| -4% | -$180K | 0.2% | 123 |
|
|
2024
Q2 | $5.19M | Sell |
28,280
-240
| -0.8% | -$44.1K | 0.21% | 111 |
|
|
2024
Q1 | $5.07M | Sell |
28,520
-3,830
| -12% | -$681K | 0.21% | 116 |
|
|
2023
Q4 | $4.01M | Buy |
32,350
+20,930
| +183% | +$2.6M | 0.18% | 136 |
|
|
2023
Q3 | $1.32M | Buy |
+11,420
| New | +$1.32M | 0.07% | 181 |
|